Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Bud BilanichSuccess Coach
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
Pat PurcellMeeting Engagement
Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], ...
YARDLEY, Pa., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or ...
SEATTLE, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email